HCPCS J0775: Collagenase, Clostridium Histolyticum Injection, 0.01 mg
HCPCS Level II code J0775 denotes a unit of injection for collagenase, clostridium histolyticum at 0.01 mg. This code is used to bill for the pharmaceutical product itself when administered as an injectable biologic and is relevant for specialists and clinics that provide enzymatic collagen degradation treatments. Nationally, accurate coding for high-cost specialty injectables matters for claim adjudication, utilization tracking, and cost management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the drug formulation, typical sites of service where the product is administered, and the payer landscape relevant to coverage and billing. The publication outlines common billing considerations, benchmark touchpoints for unit-based reporting, and where to find policy updates affecting injectable specialty drugs.
The write-up provides actionable reference material for revenue cycle, clinical coding staff, and practice managers seeking clarity on how J0775 is described, where it is typically billed, and which major payers are commonly involved. Data not available in the input is explicitly noted where applicable.
Customize your policy alerts
Sign up for hcpcs J0775 policy alerts
Get alerted when payer policies referencing J0775 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code J0775 represents the drug injection collagenase, clostridium histolyticum, billed per unit of 0.01 mg. This code covers the pharmaceutical product formulation used for enzymatic collagen degradation in clinical indications where collagenase injection is an established therapy.
Service Type: Medication administration / injectable biologic
Typical Site of Service: Outpatient clinic or physician office, including ambulatory infusion or procedure suites where injections of specialty biologics are administered.